Amphastar Pharmaceuticals (AMPH) EBT Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) EBT Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.64 Mn | 644.51 Mn | 93.47 Mn | -2.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.01% |
| Mar 31, 2026 | -67.43% |
| Dec 31, 2025 | -27.41% |
| Sep 30, 2025 | -54.88% |
| Jun 30, 2025 | -21.71% |
| Mar 31, 2025 | -35.54% |
| Dec 31, 2024 | 131.27% |
| Sep 30, 2024 | -25.07% |
| Jun 30, 2024 | 53.14% |
| Mar 31, 2024 | 42.62% |
| Dec 31, 2023 | -440.71% |
| Sep 30, 2023 | 181.63% |
| Jun 30, 2023 | 41.71% |
| Mar 31, 2023 | 15.62% |
| Dec 31, 2022 | 51.90% |
| Sep 30, 2022 | -39.98% |
| Jun 30, 2022 | 62.84% |
| Mar 31, 2022 | 467.72% |
| Dec 31, 2021 | 502.88% |
| Sep 30, 2021 | 431.87% |